-
1
المؤلفون: Khaled Messaoudi, Patrick Saulnier, Anne Clavreul, Jean-Pierre Benoit, Fabienne Danhier, Frédéric Lagarce
المساهمون: UCL - SSS/LDRI - Louvain Drug Research Institute, Micro et Nanomédecines Biomimétiques (MINT), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Bretagne Loire (UBL), Unité de Pharmacologie Cellulaire et Moléculaire [Brussels], Louvain Drug Research Institute [Bruxelles, Belgique] (LDRI), Université Catholique de Louvain = Catholic University of Louvain (UCL)-Université Catholique de Louvain = Catholic University of Louvain (UCL), Univ Angers, Okina
المصدر: European Journal of Nanomedicine, Vol. 7, no.2, p. 97-107 (2015)
European Journal of Nanomedicine
European Journal of Nanomedicine, 2015, 7 (2), pp.97-107. ⟨10.1515/ejnm-2014-0041⟩مصطلحات موضوعية: Small interfering RNA, medicine.medical_treatment, EGFR, Biomedical Engineering, Medicine (miscellaneous), Bioengineering, [SDV.CAN]Life Sciences [q-bio]/Cancer, temozolomide, Biology, [SDV.CAN] Life Sciences [q-bio]/Cancer, SiRNA, medicine, Temozolomide, Gene silencing, galectin-1, Epidermal growth factor receptor, Physical and Theoretical Chemistry, Experimental cancer treatment, neoplasms, glioblastoma, In vitro, Gliome, 3. Good health, Concomitant, siRNA, Galectin-1, Immunology, Cancer research, biology.protein, MGMT, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::945fac43b5a05d4d80c356aab895eae5Test
https://hdl.handle.net/2078.1/168545Test -
2
المساهمون: Unité de Pharmacologie Cellulaire et Moléculaire [Brussels], Louvain Drug Research Institute [Bruxelles, Belgique] (LDRI), Université Catholique de Louvain = Catholic University of Louvain (UCL)-Université Catholique de Louvain = Catholic University of Louvain (UCL), Université Catholique de Louvain = Catholic University of Louvain (UCL), Micro et Nanomédecines Biomimétiques (MINT), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Bretagne Loire (UBL), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)
المصدر: International Journal of Pharmaceutics
International Journal of Pharmaceutics, Elsevier, 2015, 481, pp.154-161. ⟨10.1016/j.ijpharm.2015.01.051⟩مصطلحات موضوعية: Small interfering RNA, Pathology, Galectin 1, medicine.medical_treatment, [SDV]Life Sciences [q-bio], Pharmaceutical Science, Lipid nanocapsules, Drug Delivery Systems, 0302 clinical medicine, Galectin-1, Medicine, Epidermal growth factor receptor, RNA, Small Interfering, 0303 health sciences, biology, medicine.diagnostic_test, Brain Neoplasms, Lipids, Tumor Burden, 3. Good health, Dacarbazine, ErbB Receptors, 030220 oncology & carcinogenesis, Female, medicine.drug, medicine.medical_specialty, EGFR, Mice, Nude, Immunofluorescence, 03 medical and health sciences, Nanocapsules, In vivo, Cell Line, Tumor, Temozolomide, Animals, Humans, Gene Silencing, Antineoplastic Agents, Alkylating, 030304 developmental biology, Chitosan, Chemotherapy, business.industry, Radiation therapy, Drug Resistance, Neoplasm, siRNA, Cancer research, biology.protein, business, Glioblastoma
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdbc0c7b274d79cc35bf52bedb95647eTest
https://hal.archives-ouvertes.fr/hal-01392431Test -
3رسالة جامعية
المؤلفون: Khaled, Messaoudi
المساهمون: Angers, Lagarce, Frédéric, Saulnier, Patrick
مصطلحات موضوعية: Transacylation, Chitosan, SiRNA, Glioblastomas, Temozolomide, Nanocapsules, 615.6, 616.99
-
4
المساهمون: Micro et Nanomédecines Biomimétiques (MINT), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Bretagne Loire (UBL), Département de Pharmacie [CHU d'Angers], Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Univ Angers, Okina
المصدر: International Journal of Nanomedicine
International Journal of Nanomedicine, Dove Medical Press, 2014, 9, pp.1479-90. ⟨10.2147/IJN.S59134⟩
International Journal of Nanomedicine, 2014, 9, pp.1479-90. ⟨10.2147/IJN.S59134⟩مصطلحات موضوعية: Acylation, EGFR, [SDV]Life Sciences [q-bio], Cell, Biophysics, Pharmaceutical Science, Bioengineering, temozolomide, Biology, Pharmacology, Nanocapsules, Biomaterials, Transacylation, International Journal of Nanomedicine, Cell Line, Tumor, Drug Discovery, medicine, Humans, Gene Silencing, Epidermal growth factor receptor, Particle Size, RNA, Small Interfering, Cytotoxicity, Antineoplastic Agents, Alkylating, Original Research, Gene knockdown, lipid nanocapsules, Temozolomide, Organic Chemistry, glioblastoma, Drug Synergism, General Medicine, Transfection, Lipids, 3. Good health, Dacarbazine, ErbB Receptors, [SDV] Life Sciences [q-bio], Treatment Outcome, medicine.anatomical_structure, siRNA, biology.protein, chitosan, medicine.drug
وصف الملف: text/html; application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10d700b213ea3fbef74e843600d6e713Test
https://doi.org/10.2147/ijn.s59134Test
